Transplant Diagnostics Market
完整報告名稱與涵蓋範圍
Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User, By Region, And Segment Forecasts, 2025-2034
報告摘要
The Transplant Diagnostics Market on a global scale was estimated at USD 4.9 Bn in 2024 and is poised to attain USD 10.4 Bn by 2034, with a projected CAGR of 7.9% between 2025 and 2034.
At its core, Transplant Diagnostics pertains to The rise in organ transplants represents a considerable aspect driving demand for diagnostics utilized before surgery. Stakeholders across the healthcare landscape are surgingly turning to these solutions to meet contemporary demands.
Market momentum is driven by surging appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Transplant Diagnostics Market Snapshot
Chapter 4. Global Transplant Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Molecular assay technologies
5.2.1.1. PCR-based molecular assays
5.2.1.2. Real-time PCR
5.2.1.3. Sequence-specific primer-PCR
5.2.1.4. Sequence-specific Oligonucleotide-PCR
5.2.1.5. Other PCR-based molecular assays
5.2.2. Sequencing based molecular assays
5.2.2.1. Sanger sequencing
5.2.2.2. Next generation sequencing
5.2.2.3. Other sequencing based molecular assays
5.2.3. Non molecular assays technologies
Chapter 6. Market Segmentation 2: by Product & Service Estimates & Trend Analysis
6.1. by Product & Service & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
6.2.1. Reagents & Consumables
6.2.2. Instruments
6.2.3. Software & Services
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Diagnostic Application
7.2.1.1. Pre-Transplantation Diagnostics
7.2.1.1.1. Infectious Disease Testing
7.2.1.1.2. Histocompatibility Testing
7.2.1.1.3. Blood Profiling
7.2.1.2. Post -Transplantation Diagnostics
7.2.2. Research Applications
Chapter 8. Market Segmentation 4: by Transplant Type Estimates & Trend Analysis
8.1. by Transplant Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Transplant Type:
8.2.1. Solid Organ Transplantation
8.2.1.1. Kidney Transplantation
8.2.1.2. Liver Transplantation
8.2.1.3. Heart Transplantation
8.2.1.4. Lung Transplantation
8.2.1.5. Pancreases Transplantation
8.2.1.6. Other Organs Transplantation
8.2.2. Stem Cell Transplantation
8.2.3. Soft Tissue Transplantation
8.2.4. Bone Marrow Transplantation
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
9.2.1. Hospitals and Transplant centers
9.2.2. Research &Academic Institutes
9.2.3. Independent reference laboratories
Chapter 10. Transplant Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.1.2. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
10.1.3. North America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.1.4. North America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.1.5. North America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.1.6. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.2.2. Europe Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.2.3. Europe Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.2.4. Europe Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.2.5. Europe Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.2.6. Europe Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.3.2. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.3.3. Asia-Pacific Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.3.4. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.3.5. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.3.6. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.4.2. Latin America Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.4.3. Latin America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.4.4. Latin America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.4.5. Latin America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.4.6. Latin America Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.5.2. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.5.3. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.5.4. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.5.5. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.5.6. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories, Inc.
11.2.2. Adaptive Biotechnologies
11.2.3. Affymetrix, Inc.
11.2.4. altona Diagnostics GmbH
11.2.5. Arquer Diagnostics Ltd
11.2.6. BAG Diagnostics GmbH
11.2.7. Becton, Dickinson and Company,
11.2.8. Biofortuna Limited
11.2.9. BioMerieux SA,
11.2.10. Bio-rad Laboratories, Inc.
11.2.11. Biotype GmbH
11.2.12. Bruker,
11.2.13. CareDx Inc.
11.2.14. CLONIT srl
11.2.15. Diagnóstica Longwood SL
11.2.16. DiaSorin S.p.A.
11.2.17. ELITechGroup
11.2.18. EUROFINS VIRACOR
11.2.19. F. Hoffmann La-Roche AG.
11.2.20. Hologic, Inc.
11.2.21. Horiba Ltd
11.2.22. Illumina, Inc.
11.2.23. Immucor Transplant Diagnostics, Inc.
11.2.24. Laboratory Corporation of America Holdings.
11.2.25. Linkage Biosciences
11.2.26. Luminex Corporation
11.2.27. Merck KGaA
11.2.28. NanoString
11.2.29. Olerup SSP AB
11.2.30. Omixon Ltd.
11.2.31. PathoNostics
11.2.32. Preservation Solutions, Inc.
11.2.33. Qiagen N.V.
11.2.34. Randox Laboratories Ltd.
11.2.35. Stryker
11.2.36. Takara Bio Inc.
11.2.37. Thermo Fisher Scientific,
11.2.38. TransMedics
11.2.39. Transonic
11.2.40. Zimmer Biomet
11.2.41. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們